ArticleJSES international2026
Establishing procedure-specific minimal clinically important difference and patient acceptable symptom state thresholds after anterior combined latissimus dorsi and teres major tendon transfer for irreparable anterosuperior cuff tears: minimum 5-year outcomes.
Article in JSES international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To date, no prior study has established procedure-specific minimal clinically important difference (MCID) and patient acceptable symptom state (PASS) thresholds for anterior combined latissimus dorsi and teres major (LDTM) tendon transfer in irreparable anterosuperior rotator cuff tears (IASRCTs). This study aimed to establish these patient-centered benchmarks in a cohort with a minimum 5-year follow-up. Methods: We retrospectively reviewed 31 patients (33 shoulders) who underwent a single-stage anterior LDTM transfer for IASRCTs and completed a minimum 5-year follow-up. Patient-reported outcome measures (PROMs) included the American Shoulder and Elbow Surgeons (ASES) score, visual analog scale (VAS) for pain, Constant score, and activities of daily living requiring internal rotation (ADLIR) score. The MCID was calculated as one-half of the standard deviation of the change score for each PROMs. PASS thresholds were derived from receiver operating characteristic analysis, using postoperative satisfaction as the external anchor. Results: At a mean follow-up of 83.0 ± 7.4 months, all PROMs improved significantly ( Conclusion: This study is the first to establish clinically meaningful MCID and PASS thresholds for anterior LDTM transfer in patients with IASRCTs at a minimum 5-year follow-up. Most patients achieved substantial improvements that were deemed acceptable by the patients. These procedure-specific benchmarks provide practical targets for clinical assessment and patient counseling and serve as reference values for future outcome research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.